Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1869-6961
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective ; day:23 ; month:8 ; year:2016 ; pages:1-15
Diabetes therapy ; (23.8.2016), 1-15

Creator
Evans, Marc
Contributor
Gundgaard, Jens
Hansen, Brian Bekker
SpringerLink (Online service)

DOI
10.1007/s13300-016-0195-6
URN
urn:nbn:de:1111-2016092018795
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Evans, Marc
  • Gundgaard, Jens
  • Hansen, Brian Bekker
  • SpringerLink (Online service)

Other Objects (12)

Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study

Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study

Biphasic human insulin 30 thrice daily, is it reasonable?

Biphasic human insulin 30 thrice daily, is it reasonable?

Penicillin und Insulin: Insulin.- Bedarf

Schriftgut

Penicillin und Insulin: Insulin.- Bedarf

Insulin

Insulin

Insulin

Schriftgut

Insulin

Insulin

Archivale

Insulin

Insulin

Insulin

Insulin

Archivale

Insulin

Insulin

Schriftgut

Insulin

Insulin

Insulin

Insulin

Archivale

Insulin

Insulin

Archivale

Insulin

Related objects